Disease Presentation, Treatment Options, and Outcomes for Myeloid Immunodeficiencies.
Disease Presentation, Treatment Options, and Outcomes for Myeloid Immunodeficiencies.
复制标题
DOI:
10.1007/s11882-020-00984-8
复制
发表时间:
2021-03-05
影响因子:
5.5
通讯作者:
Kang EM
中科院分区:
文献类型:
--
作者:
Kang EM
Up to date review on various types of immunodeficiencies with a significant myeloid component including some more recently described congenital disorders. Neutrophils (or granulocytes) are a major contributor to infection surveillance and clearance and defective neutrophils characteristically lead to pyogenic infections. Deficiency in numbers, either iatrogenic or congenital, functional defects, and/or inability to target to the sites of infection can all lead to serious morbidity and mortality; however, myeloid based immunodeficiencies are not all the same. Having absent neutrophils, that is neutropenia, has implications different to those of having dysfunctional neutrophils as will become evident as the various disorders are reviewed. While a number of disorders have been described in the past, genetic sequencing has led to the identification of the specific disorders and clarified their pathophysiology. Advances in genetic therapies including genetic editing should provide future treatments beyond hematopoieitic stem cell transplant for patients with these rare disorders
登录
查看更多内容
影响因子:
3.2
作者:
Dale DC;Bolyard AA
通讯作者:
Bolyard AA
影响因子:
8.6
作者:
Essa, Mohammed F.;Elbashir, Enas;Alsultan, Abdulrahman
通讯作者:
Alsultan, Abdulrahman
影响因子:
12.4
作者:
Bauer, Thomas R., Jr.;Tuschong, Laura M.;Hickstein, Dennis D.
通讯作者:
Hickstein, Dennis D.
影响因子:
20.3
作者:
DeLisser, HM;Christofidou-Solomidou, M;Sullivan, KE
通讯作者:
Sullivan, KE
影响因子:
7.3
作者:
Drummond RA;Franco LM;Lionakis MS
通讯作者:
Lionakis MS